Gwen A. Fyfe - Net Worth and Insider Trading
Gwen A. Fyfe Net Worth
The estimated net worth of Gwen A. Fyfe is at least $33,387 dollars as of 2024-04-24. Gwen A. Fyfe is the Director of Cascadian Therapeutics Inc and owns about 3,332 shares of Cascadian Therapeutics Inc (CASC) stock worth over $33,387. Details can be seen in Gwen A. Fyfe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gwen A. Fyfe has not made any transactions after 2017-03-28 and currently still holds the listed stock(s).
Transaction Summary of Gwen A. Fyfe
Gwen A. Fyfe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gwen A. Fyfe owns 2 companies in total, including Cascadian Therapeutics Inc (CASC) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Gwen A. Fyfe’s form 4 insider trades.
Insider Ownership Summary of Gwen A. Fyfe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CASC | Cascadian Therapeutics Inc | 2018-03-09 | director |
| INFIQ | Infinity Pharmaceuticals Inc | 2012-03-08 | director |
Gwen A. Fyfe Latest Holdings Summary
Gwen A. Fyfe currently owns a total of 1 stock. Gwen A. Fyfe owns 3,332 shares of Cascadian Therapeutics Inc (CASC) as of March 28, 2017, with a value of $33,387.
Latest Holdings of Gwen A. Fyfe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CASC | Cascadian Therapeutics Inc | 2017-03-28 | 3,332 | 10.02 | 33,387 |
Holding Weightings of Gwen A. Fyfe
Gwen A. Fyfe Form 4 Trading Tracker
According to the SEC Form 4 filings, Gwen A. Fyfe has made a total of 0 transactions in Cascadian Therapeutics Inc (CASC) over the past 5 years. The most-recent trade in Cascadian Therapeutics Inc is the acquisition of 1,666 shares on March 28, 2017, which cost Gwen A. Fyfe around $6,864.
Insider Trading History of Gwen A. Fyfe
- 1
Gwen A. Fyfe Trading Performance
GuruFocus tracks the stock performance after each of Gwen A. Fyfe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gwen A. Fyfe is 3.4%. GuruFocus also compares Gwen A. Fyfe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gwen A. Fyfe within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gwen A. Fyfe's insider trading performs compared to the benchmark.
Performance of Gwen A. Fyfe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.16 | 3.4 | -0.49 | |||
| Relative Return to S&P 500(%) | 2.07 | -0.08 | -6.91 |
Gwen A. Fyfe Ownership Network
Ownership Network List of Gwen A. Fyfe
Ownership Network Relation of Gwen A. Fyfe
Gwen A. Fyfe Owned Company Details
What does Cascadian Therapeutics Inc do?
Who are the key executives at Cascadian Therapeutics Inc?
Gwen A. Fyfe is the director of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .
Cascadian Therapeutics Inc (CASC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cascadian Therapeutics Inc Insider Transactions
Gwen A. Fyfe Mailing Address
Above is the net worth, insider trading, and ownership report for Gwen A. Fyfe. You might contact Gwen A. Fyfe via mailing address: C/o Array Biopharma Inc., 3200 Walnut Street, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
